Monitoring in Neurointensive Care – The Challenge to Detect Delayed Cerebral Ischemia in High-Grade Aneurysmal SAH
نویسندگان
چکیده
Delayed cerebral ischemia (DCI) is a feared and significant medical complication following aneurysmal subarachnoid hemorrhage (aSAH). It occurs in about 30% of patients surviving the initial hemorrhage, mostly between days 4 and 10 after aSAH. Clinical deterioration attributable to DCI is a diagnosis of exclusion and especially difficult to diagnose in patients who are comatose or sedated. The latter are typically patients with a high grade on the World Federation of Neurosurgical Societies scale (WFNS grade 4-5), who represent approximately 40-70% of the patient population with ruptured aneurysms. In this group of patients, the incidence of DCI is often underestimated and higher when compared to low WFNS grade patients. To overcome difficulties in diagnosing DCI, which is especially relevant in sedated and comatose patients, the article reports the most recent recommendation for definition of DCI and discusses their advantages and problematic issues in neurocritical care practice. Finally, appropriate neuromonitoring techniques and their clinical impact in high-grade SAH patients are summarized.
منابع مشابه
Endothelial and Glycocalyx Proteins as Biomarkers in Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage
Delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH) remains a relevant issue in the critical care management of patients following aneurysm repair. It is thought to contribute to poor neurologic outcome in up to 30% of patients following SAH [1] and vigilance for delayed neurologic deterioration in the ICU remains high to prevent prolonged periods of unattended i...
متن کاملEARLYDRAIN- outcome after early lumbar CSF-drainage in aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial
BACKGROUND Aneurysmal subarachnoid hemorrhage (SAH) may be complicated by delayed cerebral ischemia, which is a major cause of unfavorable clinical outcome and death in SAH-patients. Delayed cerebral ischemia is presumably related to the development of vasospasm triggered by the presence of blood in the basal cisterns. To date, oral application of the calcium antagonist nimodipine is the only p...
متن کاملDetection delayed cerebral ischemia by qeeg in patients with acute SAH
Introduction SAHis one of the most common pathology in neurointensive care. There is a complication of SAHcerebral vasospasm (CV), which contributes significant mortality and morbidity. CV is believed to be the origin of Delayed Cerebral Ischemia (DCI). There are different methods to diagnose DCI and CV: neurological exam, MRI, CT, TCD and angiography, but they can’t detect ischemia on early st...
متن کاملسطح سرمی منیزیم و پیآمد بالینی خونریزی زیر عنکبوتیه آنوریسمال: مطالعه در 60 بیمار
Background: Hypomagnesemia is commonly encountered in patients with a wide variety of diseases including subarachnoid hemorrhage (SAH), cardiovascular emergencies, head trauma, migraine attacks, seizure and preeclampsia. It seems to be associated with a poor clinical outcome. This study considers the prevalence and temporal distribution of hypomagnesemia after aneurysmal SAH and its correlation...
متن کاملClinical Use of Cerebral Microdialysis in Patients with Aneurysmal Subarachnoid Hemorrhage—State of the Art
Objective To review the published literature on the clinical application of cerebral microdialysis (CMD) in aneurysmal subarachnoid hemorrhage (SAH) patients and to summarize the evidence relating cerebral metabolism to pathophysiology, secondary brain injury, and outcome. Methods Study selection: Two reviewers identified all manuscripts reporting on the clinical use of CMD in aneurysmal SAH ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 5 شماره
صفحات -
تاریخ انتشار 2014